 |
Product
| 2-Phase Melafadin Concentrate 4x10ml |
| Price: Contact Us | Item # 3370 |
| Product Description |
The 2-Phase Melafadin Concentrate from Janssen Cosmetics is a two-phase active concentrate designed to brighten the skin and even out the complexion.
Benefits: - Improves skin tone uniformity. - Reduces pigmentation spots. - Provides a brighter and more radiant complexion.
Active ingredients: - Vitamin C phosphate: Stabilized ascorbic acid that inhibits melanin maturation, contributing to a brighter complexion. - Lipoamino acid (INCI: Undecylenoyl Phenylalanine): An effective brightening agent that blocks α-MSH receptors on melanocytes, inhibiting melanin production. - White mulberry root extract (Morus alba): Inhibits tyrosinase and stabilizes it in its inactive form, reducing melanin production. - SORR plant extract: A potent blend of Siegesbeckia orientalis and Rabdosia rubescens that inhibits melanin absorption in keratinocytes, with soothing and antioxidant effects, promoting a radiant and even complexion.
Skin type: Suitable for fair skin and uneven complexions.
Contraindications: For external use only.
How to use: This concentrate is designed for a 40-day treatment. The contents of one ampoule are sufficient for about 10 days and consist of a powder phase and a liquid phase. Before the first use, mix the two phases by pressing firmly on the red button on the sealing cap. The vitamin C powder will fall into the activating liquid. Then remove the push-button, place the dropper with the sealing cap on the ampoule, and shake well. Apply about 1 ml of the solution to cleansed skin each morning and evening. For best results, use Brightening Day Protection in the morning and Brightening Night Care in the evening.
Precautions: After each brightening treatment, it is essential to ensure adequate UV protection.
Summary: The 2-Phase Melafadin Concentrate from Janssen Cosmetics is a two-phase active concentrate designed to brighten the skin and even out the complexion, providing a brighter and more radiant skin. |
|
 |
|
|